| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
RESEARCH COMMUNICATION |
a Université de CAEN, CNRS UMR 6551, Laboratoire de Neurosciences, bd H. Becquerel, BP 5229, 14074 CAEN Cedex, France
Serine proteases play a key role in the fundamental biology of the central nervous system (CNS), and recent data suggest their involvement in the pathophysiology of neurodegenerative diseases. Little is known about the physiological regulation of these proteases in the CNS. Among the multiple growth factors present in the brain, transforming growth factor ß1 (TGF-ß1) has been described as an injury-related growth factor. However, its beneficial or deleterious role remains unclear. In the present study, we investigated the influence of TGF-ß1 in apoptosis and necrosis, two mechanisms involved in ischemic neuronal death. We show that TGF-ß1 exerts a neuroprotective role restricted to necrosis induced by N-methyl-D-aspartate. This effect is observable only in the obligatory presence of TGF-ß1-responsive astrocytes. We demonstrate that this neuroprotective activity is mediated through an up-regulation of a serine protease inhibitor (PAI-1) in astrocytes. These results underline the involvement of serine proteases and extracellular matrix components such as the PAI-1/t-PA axis in the excitotoxic cascade. Moreover, regardless of the underlying mechanisms of t-PA involvement in excitotoxic injury, our observations might warn against the use of tissular plasminogen activator as an alternative therapy for the treatment of hypoxic-ischemic injury in the brain.—Buisson, A., Nicole, O., Docagne, F., Sartelet, H., MacKenzie, E. T., Vivien, D. Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor ß1. FASEB J. 12, 1683–1691 (1998)
Key Words: excitotoxicity • serpins • neuronal cell death • apoptosis
This article has been cited by other articles:
|
|
 |
|
  Y. Iwata, T. Okamura, N. Ishibashi, D. Zurakowski, H. G.W. Lidov, and R. A. Jonas Optimal dose of aprotinin for neuroprotection and renal function in a piglet survival model. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1521 - 1529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lebeurrier, S. Launay, R. Macrez, E. Maubert, H. Legros, A. Leclerc, S. P. Jamin, J.-Y. Picard, S. Marret, V. Laudenbach, et al. Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin J. Cell Sci., October 15, 2008; 121(20): 3357 - 3365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Qian, S.-J. Wei, D. Zhang, X. Hu, Z. Xu, B. Wilson, J. El-Benna, J.-S. Hong, and P. M. Flood Potent Anti-Inflammatory and Neuroprotective Effects of TGF-{beta}1 Are Mediated through the Inhibition of ERK and p47phox-Ser345 Phosphorylation and Translocation in Microglia J. Immunol., July 1, 2008; 181(1): 660 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Iwata, O. Nicole, T. Okamura, D. Zurakowski, and R. A. Jonas Aprotinin confers neuroprotection by reducing excitotoxic cell death J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 573 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Luo, A. H. Lin, E. Masliah, and T. Wyss-Coray Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration PNAS, November 28, 2006; 103(48): 18326 - 18331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-G. Konig, D. Kogel, A. Rami, and J. H.M. Prehn TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling J. Cell Biol., March 28, 2005; 168(7): 1077 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fernandez-Monreal, J. P. Lopez-Atalaya, K. Benchenane, M. Cacquevel, F. Dulin, J.-P. Le Caer, J. Rossier, A.-C. Jarrige, E. T. MacKenzie, N. Colloc'h, et al. Arginine 260 of the Amino-terminal Domain of NR1 Subunit Is Critical for Tissue-type Plasminogen Activator-mediated Enhancement of N-Methyl-D-aspartate Receptor Signaling J. Biol. Chem., December 3, 2004; 279(49): 50850 - 50856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lesne, F. Docagne, C. Gabriel, G. Liot, D. K. Lahiri, L. Buee, L. Plawinski, A. Delacourte, E. T. MacKenzie, A. Buisson, et al. Transforming Growth Factor-beta 1 Potentiates Amyloid-beta Generation in Astrocytes and in Transgenic Mice J. Biol. Chem., May 9, 2003; 278(20): 18408 - 18418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhu, G.-Y. Yang, B. Ahlemeyer, L. Pang, X.-M. Che, C. Culmsee, S. Klumpp, and J. Krieglstein Transforming Growth Factor-beta 1 Increases Bad Phosphorylation and Protects Neurons Against Damage J. Neurosci., May 15, 2002; 22(10): 3898 - 3909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Docagne, N. Colloc'h, V. Bougueret, M. Page, J. Paput, M. Tripier, P. Dutartre, E. T. MacKenzie, A. Buisson, S. Komesli, et al. A Soluble Transforming Growth Factor-beta (TGF-beta ) Type I Receptor Mimics TGF-beta Responses J. Biol. Chem., November 30, 2001; 276(49): 46243 - 46250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Depre, J. E. Tomlinson, R. K. Kudej, V. Gaussin, E. Thompson, S.-J. Kim, D. E. Vatner, J. N. Topper, and S. F. Vatner Gene program for cardiac cell survival induced by transient ischemia in conscious pigs PNAS, July 31, 2001; 98(16): 9336 - 9341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Nicole, C. Ali, F. Docagne, L. Plawinski, E. T. MacKenzie, D. Vivien, and A. Buisson Neuroprotection Mediated by Glial Cell Line-Derived Neurotrophic Factor: Involvement of a Reduction of NMDA-Induced Calcium Influx by the Mitogen-Activated Protein Kinase Pathway J. Neurosci., May 1, 2001; 21(9): 3024 - 3033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. DOCAGNE, O. NICOLE, H. H. MARTI, E. T. MacKENZIE, A. BUISSON, and D. VIVIEN Transforming growth factor-{beta}1 as a regulator of the serpins/t-PA axis in cerebral ischemia FASEB J, August 1, 1999; 13(11): 1315 - 1324. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
